HomeFPSUF • OTCMKTS
add
Capha Pharmaceuticals Inc
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.07K | -13.54% |
Net income | -15.81K | 21.67% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -13.04K | 13.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.42K | -26.01% |
Total assets | 2.26K | -25.36% |
Total liabilities | 553.23K | 14.50% |
Total equity | -550.96K | — |
Shares outstanding | 64.43M | — |
Price to book | -0.00 | — |
Return on assets | -1,320.78% | — |
Return on capital | 408.86% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -15.81K | 21.67% |
Cash from operations | -10.83K | 5.63% |
Cash from investing | — | — |
Cash from financing | 11.00K | -4.35% |
Net change in cash | 171.00 | 584.00% |
Free cash flow | -3.19K | -337.91% |
About
Headquarters
